LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

Organon & Co

Ouvert

SecteurSoins de santé

8.38 -0.48

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.22

Max

8.73

Chiffres clés

By Trading Economics

Revenu

-22M

87M

Ventes

-79M

1.5B

P/E

Moyenne du Secteur

3.125

54.533

BPA

1.02

Rendement du dividende

0.89

Marge bénéficiaire

5.75

Employés

10,000

EBITDA

-13M

325M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+83.04% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.89%

2.41%

Prochains Résultats

5 août 2025

Date du Prochain Dividende

12 juin 2025

Date du Prochain Détachement de Dividende

15 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.8B

2.3B

Ouverture précédente

8.86

Clôture précédente

8.38

Sentiment de l'Actualité

By Acuity

33%

67%

91 / 382 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Organon & Co Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 mai 2025, 23:48 UTC

Actions en Tendance

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22 mai 2025, 23:07 UTC

Actualités

Fortescue Energy CEO to Resign in Executive Overhaul

22 mai 2025, 23:03 UTC

Principaux Mouvements du Marché

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22 mai 2025, 23:59 UTC

Market Talk

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22 mai 2025, 23:45 UTC

Market Talk

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22 mai 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

22 mai 2025, 23:23 UTC

Market Talk

Global Energy Roundup: Market Talk

22 mai 2025, 23:23 UTC

Market Talk

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22 mai 2025, 23:12 UTC

Actualités

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

22 mai 2025, 21:54 UTC

Actualités

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

22 mai 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

22 mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 mai 2025, 20:46 UTC

Acquisitions, Fusions, Rachats

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22 mai 2025, 20:39 UTC

Résultats

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22 mai 2025, 20:36 UTC

Actualités

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22 mai 2025, 20:36 UTC

Actualités
Résultats

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22 mai 2025, 20:32 UTC

Actualités
Résultats

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mai 2025, 20:27 UTC

Actualités

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22 mai 2025, 20:20 UTC

Actualités

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mai 2025, 20:17 UTC

Actualités

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22 mai 2025, 20:16 UTC

Résultats

Intchains Group 1Q Rev $18.2M >ICG

22 mai 2025, 20:15 UTC

Actualités

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mai 2025, 20:08 UTC

Actualités
Résultats

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mai 2025, 20:05 UTC

Actualités

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22 mai 2025, 20:04 UTC

Résultats

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22 mai 2025, 20:04 UTC

Résultats

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22 mai 2025, 20:01 UTC

Résultats

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22 mai 2025, 20:01 UTC

Résultats

Workday 1Q Net $68M >WDAY

22 mai 2025, 20:01 UTC

Résultats

Workday 1Q EPS 25c >WDAY

22 mai 2025, 20:01 UTC

Résultats

Workday 1Q Adj EPS $2.23 >WDAY

Comparaison

Variation de prix

Organon & Co prévision

Objectif de Prix

By TipRanks

83.04% hausse

Prévisions sur 12 Mois

Moyen 15.43 USD  83.04%

Haut 24 USD

Bas 10 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

3

Achat

3

Maintien

2

Vente

Score Technique

By Trading Central

8.53 / 9.18Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

91 / 382Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Organon & Co

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company's biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio. It offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Atozet, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for treatments of control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. The company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. It sells its products to drug wholesalers and retailers, hospitals, pharmacies, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. The company was incorporated in 2020 and is headquartered in Jersey City, New Jersey.